Designing in vivo bioreactors for soft tissue engineering

Journal of Biomaterials and Tissue Engineering

Volumn 2, Issue 1, 2012, Pages 1-13

  Ladewig, Katharina ^a   Abberton, Keren ^a,b   O'Connor, Andrea J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b O'Brien Institute   (Australia)

Author keywords

Bioreactors; Design principles; Soft tissue engineering; Tissue regeneration

Indexed keywords

EID: 84877667933     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2012.1028     Document Type: Review

References (93)

1. A. J. O'Connor and W. A. Morrison, Plastic Surgery, edited by P. Neligan, Elsevier, Amsterdam (2011).
2. K. Ladewig, Drug Delivery in Soft Tissue Engineering, Expert Opinion on Drug Delivery (2011), Vol. 8, pp. 1175-1188.
3. B. Hüsing, B. Bührlein, and S. Gaisser, Human Tissue Engineered Products-Today's Markets and Future Prospects, Fraunhofer Institute for Systems and Innovation Research ISI, Karlsruhe, Germany (2003).
4. Clinicaltrials. gov, accessed 1-Mar-2011.
5. P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases. Nature 407, 249 (2000).
6. R. G. Boutilier and J. St-Pierre, Surviving hypoxia without really dying. Comparative Biochemistry and Physiology a-Molecular and Integrative Physiology 126, 481 (2000).
7. T. I. Croll, S. Gentz, K. Mueller, M. Davidson, A. J. O'Connor, G. W. Stevens, and J. J. Cooper-White, Modelling oxygen diffusion and cell growth in a porous, vascularising scaffold for soft tissue engineering applications. Chemical Engineering Science 60, 4924 (2005).
8. Y. Cao, B. Zhang, T. I. Croll, B. E. Rolfe, J. H. Campbell, G. R. Campbell, D. J. Martin, and J. J. Cooper-White, Engineering tissue tubes using novel multilayered scaffolds in the rabbit and rat peritoneal cavity. Tissue Engineering 12, 108 (2006).
9. M. K. Smith and D. J. Mooney, Hypoxia leads to necrotic hepatocyte death. J. Biomed. Mater. Res. Part A 80A, 520 (2007).
10. Z. Lokmic and G. M. Mitchell, Engineering the microcirculation. Tissue Engineering Part B-Reviews 14, 87 (2008).
11. Z. Lokmic, F. Stillaert, W. A. Morrison, E. W. Thompson, and G. M. Mitchell, An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. Faseb Journal 21, 511 (2007).
12. M. T. Yang, J. P. Fu, Y. K. Wang, R. A. Desai, and C. S. Chen, Assaying stem cell mechanobiology on microfabricated elastomeric substrates with geometrically modulated rigidity. Nature Protocols 6, 187 (2011).
13. A. J. Engler, S. Sen, H. L. Sweeney, and D. E. Discher, Matrix elasticity directs stem cell lineage specification. Cell 126, 677 (2006).
14. A. V. Vashi, K. M. Abberton, G. P. Thomas, W. A. Morrison, A. J. O'Connor, J. J. Cooper-White, and E. W. Thompson, Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Engineering 12, 3035 (2006).
15. D. Wendt and S. A. Riboldi, Fundamentals of Tissue Engineering and Regenerative Medicine, edited by U. Meyer, T. Meyer, J. Handschel, and H. P. Wiesmann, Springer-Verlag, Berlin-Heidelberg (2009), p. 595.
16. S. J. Hollister, Scaffold design and manufacturing: From concept to clinic. Advanced Materials 21, 3330 (2009).
17. J. H. Choi, J. M. Gimble, K. Lee, K. G. Marra, J. P. Rubin, J. J. Yoo, G. Vunjak-Novakovic, and D. L. Kaplan, Adipose tissue engineering for soft tissue regeneration. Tissue Engineering Part B-Reviews 16, 413 (2010).
18. J. C. Middleton and A. J. Tipton, Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21, 2335 (2000).
19. K. W. Ng, D. W. Hutmacher, J.-T. Schantz, C. S. Ng, H.-P. Too, T. C. Lim, T. T. Phan, and S. H. Teoh, Evaluation of ultra-thin poly(OEμ-caprolactone) films for tissue-engineered skin. Tissue Eng. 7, 441 (2001).
20. L. Savarino, N. Baldini, M. Greco, O. Capitani, S. Pinna, S. Valentini, B. Lombardo, M. T. Esposito, L. Pastore, L. Ambrosio, S. Battista, F. Causa, S. Zeppetelli, V. Guarino, and P. A. Netti, The performance of poly-OEμ-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials 28, 3101 (2007).
21. M. Biondi, L. Indolfi, F. Ungaro, F. Quaglia, M. I. Rotonda, and P. A. Netti, Bioactivated collagen-based scaffolds embedding proteinreleasing biodegradable microspheres: Tuning of protein release kinetics. J. Mater. Sci.: Mater. Med. 20, 2117 (2009).
22. X. Shi, Y. Wang, R. R. Varshney, L. Ren, Y. Gong, and D.-A. Wang, Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro. European Journal of Pharmaceutical Sciences 39, 59 (2010).
23. R. M. Day, A. R. Boccaccini, V. Maquet, S. Shurey, A. Forbes, S. M. Gabe, and R. Jerome, In vivo characterization of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J. Mater. Sci.: Mater. Med. 15, 729 (2004).
24. I. Grizzi, H. Garreau, S. Li, and M. Vert, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials 16, 305 (1995).
25. Y.-C. Huang, D. Kaigler, K. G. Rice, P. H. Krebsbach, and D. J. Mooney, Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. Journal of Bone and Mineral Research 20, 848 (2005).
26. O. Jeon, S. J. Song, S.-W. Kang, A. J. Putnam, and B.-S. Kim, Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lacticco-glycolic acid) scaffold. Biomaterials 28, 2763 (2007).
27. M. P. Lutolf and J. A. Hubbell, Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47 (2005).
28. M. H. Fittkau, P. Zilla, D. Bezuidenhout, M. P. Lutolf, P. Human, J. A. Hubbell, and N. Davies, The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials 26, 167 (2005).
29. T. A. Holland, Y. Tabata, and A. G. Mikos, Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. Journal of Controlled Release 101, 111 (2005).
30. T. Suciati, D. Howard, J. Barry, N. M. Everitt, K. M. Shakesheff, and F. R. A. J. Rose, Zonal release of proteins within tissue engineering scaffolds. J. Mater. Sci.: Mater. Med. 17, 1049 (2006).
31. S. J. Peter, L. Lu, D. J. Kim, G. N. Stamatas, M. J. Miller, M. J. Yaszemski, and A. G. Mikos, Effects of transforming growth factor OE ≤ 1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J. Biomed. Mater. Res. 50, 452 (2000).
32. J. S. Temenoff, K. A. Athanasiou, R. G. LeBaron, and A. G. Mikos, Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J. Biomed. Mater. Res. 59, 429 (2002).
33. J. P. Jain, S. Modi, A. J. Domb, and N. Kumar, Role of polyanhydrides as localized drug carriers. Journal of Controlled Release 103, 541 (2005).
34. N. Kumar, R. S. Langer, and A. J. Domb, Polyanhydrides: An overview. Advanced Drug Delivery Reviews 54, 889 (2002).
35. X. Liu, G. J. Pettway, L. K. McCauley, and P. X. Ma, Pulsatile release of parathyroid hormone from an implantable delivery system. Biomaterials 28, 4124 (2007).
36. C. A. Van Blitterswijk, Tissue Engineering, Elsevier Academic Press, Amsterdam, London (2008).
37. A. H. Reddi, Growth factors and morphogens: Signals for tissue engineering. Tissue Eng. 2/1 (2007).
38. V. Mourino and A. R. Boccaccini, Bone tissue engineering therapeutics: Controlled drug delivery in three-dimensional scaffolds. Journal of the Royal Society, Interface 7, 209 (2010).
39. C. Plank, U. Schillinger, C. Hacker, T. Brill, C. Rudolph, F. Kroetz, J. Hirschberger, A. Stemberger, and B. Gaensbacher, Localized nucleic acid delivery to living cells using nanobiotechnology approaches. IEEE-NANO 2004, Fourth IEEE Conference on Nanotechnology, Muenchen, Germany, August (2004), p. 328.
40. P. S. Stayton, M. E. H. El-Sayed, N. Murthy, V. Bulmus, C. Lackey, C. Cheung, and A. S. Hoffman, 'Smart' delivery systems for biomolecular therapeutics. Orthodontics and Craniofacial Research 8, 219 (2005).
41. L. Shea, E. Smiley, J. Bonadio, and D. J. Mooney, DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551 (1999).
42. N. Forster, J. A. Palmer, G. Yeoh, W. C. Ong, G. M. Mitchell, J. Slavin, J. Tirnitz-Parker, and W. A. Morrison, Expansion and hepatocytic differentiation of liver progenitor cells in vivo using a vascularized tissue engineering chamber in mice. Tissue Engineering Part C-Methods 17, 359 (2011).
43. A. J. Hussey, M. Winardi, J. Wilson, N. Forster, W. A. Morrison, A. J. Penington, K. R. Knight, and S. J. Feeney, Pancreatic islet transplantation using vascularised chambers containing nerve growth factor ameliorates hyperglycaemia in diabetic mice. Cells Tissues Organs 191, 382 (2010).
44. A. J. Hussey, M. Winardi, X. L. Han, G. P. L. Thomas, A. J. Penington, W. A. Morrison, K. R. Knight, and S. J. Feeney, Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Engineering Part A 15, 3823 (2009).
45. J. H. Dolderer, K. M. Abberton, E. W. Thompson, J. L. Slavin, G. W. Stevens, A. J. Penington, and W. A. Morrison, Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space. Tissue Engineering 13, 673 (2007).
46. F. Stillaert, M. Findlay, J. Palmer, R. Idrizi, S. Cheang, A. Messina, K. Abberton, W. Morrison, and E. W. Thompson, Host rather than graft origin of matrigel-induced adipose tissue in the murine tissueengineering chamber. Tissue Engineering 13, 2291 (2007).
47. K. J. Cronin, A. Messina, K. R. Knight, J. J. Cooper-White, G. W. Stevens, A. J. Penington, and W. A. Morrison, New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plastic and Reconstructive Surgery 113, 260 (2004).
48. R. L. Walton, E. K. Beahm, and L. Wu, De novo adipose formation in a vascularized engineered construct. Microsurgery 24, 378 (2004).
49. M. L. Moya, M. H. Cheng, J. J. Huang, M. E. Francis-Sedlak, S. W. Kao, E. C. Opara, and E. M. Brey, The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials 31, 2816 (2010).
50. J. L. Kelly, M. W. Findlay, K. R. Knight, A. Penington, E. W. Thompson, A. Messina, and W. A. Morrison, Contact with existing adipose tissue is inductive for adipogenesis in Matrigel. Tissue Engineering 12, 2041 (2006).
51. J. A. Rophael, R. O. Craft, J. A. Palmer, A. J. Hussey, G. P. L. Thomas, W. A. Morrison, A. J. Penington, and G. M. Mitchell, Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. American Journal of Pathology 171, 2048 (2007).
52. D. M. Hoganson, J. L. Anderson, E. F. Weinberg, E. J. Swart, B. K. Orrick, J. T. Borenstein, and J. P. Vacanti, Branched vascular network architecture: A new approach to lung assist device technology. Journal of Thoracic and Cardiovascular Surgery 140, 990 (2010).
53. W. M. Hsu, A. Carraro, K. M. Kulig, M. L. Miller, M. Kaazempur-Mofrad, E. Weinberg, F. Entabi, H. Albadawi, M. T. Watkins, J. T. Borenstein, J. P. Vacanti, and C. Neville, Liver-assist device with a microfluidics-based vascular bed in an animal model. Annals of Surgery 252, 351 (2010).
54. J. T. Borenstein, E. J. Weinberg, B. K. Orrick, C. Sundback, M. R. Kaazempur-Mofrad, and J. P. Vacanti, Microfabrication of three-dimensional engineered scaffolds. Tissue Engineering 13, 1837 (2007).
55. C. Fidkowski, M. R. Kaazempur-Mofrad, J. Borenstein, J. P. Vacanti, R. Langer, and Y. D. Wang, Endothelialized microvasculature based on a biodegradable elastomer. Tissue Engineering 11, 302 (2005).
56. K. R. King, C. C. J. Wang, M. R. Kaazempur-Mofrad, J. P. Vacanti, and J. T. Borenstein, Biodegradable microfluidics. Adv. Mater. 16, 2007 (2004).
57. J. T. Borenstein, H. Terai, K. R. King, E. J. Weinberg, M. R. Kaazempur-Mofrad, and J. P. Vacanti, Microfabrication technology for vascularized tissue engineering. Biomed. Microdevices 4, 167 (2002).
58. S. Kaihara, J. Borenstein, R. Koka, S. Lalan, E. R. Ochoa, M. Ravens, H. Pien, B. Cunningham, and J. P. Vacanti, Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Engineering 6, 105 (2000).
59. K. Jakab, C. Norotte, B. Damon, F. Marga, A. Neagu, C. L. Besch-Williford, A. Kachurin, K. H. Church, H. Park, V. Mironov, R. R. Markwald, G. Vunjak-Novakovic, and G. Forgacs, Tissue engineering by self-assembly of cells printed into topologically defined structures. Tissue Engineering Part A 14, 413 (2008).
60. K. Jakab, C. Norotte, F. Marga, K. Murphy, G. Vunjak-Novakovic, and G. Forgacs, Tissue engineering by self-assembly and bioprinting of living cells. Biofabrication 2, 022001 (2010).
61. C. Norotte, F. S. Marga, L. E. Niklason, and G. Forgacs, Scaffoldfree vascular tissue engineering using bioprinting. Biomaterials 30, 5910 (2009).
62. C. J. Bettinger, E. J. Weinberg, K. M. Kulig, J. P. Vacanti, Y. D. Wang, J. T. Borenstein, and R. Langer, Three-dimensional microfluidic tissue-engineering scaffolds using a flexible biodegradable polymer. Adv. Mater. 18, 165 (2006).
63. A. Carraro, W. M. Hsu, K. M. Kulig, W. S. Cheung, M. L. Miller, E. J. Weinberg, E. F. Swart, M. Kaazempur-Mofrad, J. T. Borenstein, J. P. Vacanti, and C. Neville, In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed. Microdevices 10, 795 (2008).
64. C. S. Fritsche, O. Simsch, E. J. Weinberg, B. Orrick, C. Stamm, M. R. Kaazempur-Mofrad, J. T. Borenstein, R. Hetzer, and J. P. Vacanti, Pulmonary tissue engineering using dual-compartment polymer scaffolds with integrated vascular tree. International Journal of Artificial Organs 32, 701 (2009).
65. S. O. P. Hofer, K. M. Knight, J. J. Cooper-White, A. J. O'Connor, J. M. Perera, R. Romeo-Meeuw, A. J. Penington, K. R. Knight, W. A. Morrison, and A. Messina, Increasing the volume of vascularized tissue formation in engineered constructs: An experimental study in rats. Plastic and Reconstructive Surgery 111, 1186 (2003).
66. A. N. Morritt, S. K. Bortolotto, R. J. Dilley, X. L. Han, A. R. Kompa, D. McCombe, C. E. Wright, S. Itescu, J. A. Angus, and W. A. Morrison, Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115, 353 (2007).
67. Y. Tanaka, A. Tsutsumi, D. M. Crowe, S. Tajima, and W. A. Morrison, Generation of an autologous tissue (matrix) flap by combining an arteriovenous shunt loop with artificial skin in rats: Preliminary report. British Journal of Plastic Surgery 53, 51 (2000).
68. D. J. Tilkorn, A. Bedogni, E. Keramidaris, X. L. Han, J. A. Palmer, A. M. Dingle, B. S. Cowling, M. D. Williams, S. M. McKay, L. Pepe, A. Deftereos, W. A. Morrison, A. J. Penington, and G. M. Mitchell, Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation/prevascularization tissue engineering model. Tissue Engineering Part A 16, 165 (2010).
69. J. W. Simcock, A. J. Penington, W. A. Morrison, E. W. Thompson, and G. M. Mitchell, Endothelial precursor cells home to a vascularized tissue engineering chamber by application of the angiogenic chemokine CXCL12. Tissue Engineering Part A 15, 655 (2009).
70. R. A. Mian, K. R. Knight, A. J. Penington, J. V. Hurley, A. Messina, R. Romeo, and W. A. Morrison, Stimulating effect of an arteriovenous shunt on the in vivo growth of isografted fibroblasts: A preliminary report. Tissue Engineering 7, 73 (2001).
71. N. Seach, M. Mattesich, K. Abberton, K. Matsuda, D. J. Tilkorn, J. Rophael, R. L. Boyd, and W. A. Morrison, Vascularized tissue engineering mouse chamber model supports thymopoiesis of ectopic thymus tissue grafts. Tissue Engineering Part C-Methods 16, 543 (2010).
72. A. Messina, S. K. Bortolotto, O. C. S. Cassell, J. Kelly, K. M. Abberton, and W. A. Morrison, Generation of a vascularized organoid using skeletal muscle as the inductive source. Faseb Journal 19, 1570 (2005).
73. M. W. Findlay, A. Messina, E. W. Thompson, and W. A. Morrison, Long-term persistence of tissue-engineered adipose flaps in a murine model to 1 year: An update. Plastic and Reconstructive Surgery 124, 1077 (2009).
74. L. A. Galea, H. E. Lilja, G. P. L. Thoma, K. M. Abberton, J. A. Palmer, and W. A. Morrison, Tissue Engineering: From Lab to Clinic, edited by N. Pallula and C. V. Suschek, Springer, Berlin, Heidelberg, Germany (2011).
75. J. A. McKee, S. S. R. Banik, M. J. Boyer, N. M. Hamad, J. H. Lawson, L. E. Niklason, and C. M. Counter, Human arteries engineered in vitro. Embo Reports 4, 633 (2003).
76. J. H. Campbell, J. L. Efendy, and G. R. Campbell, Novel vascular graft grown within recipient's own peritoneal cavity. Circulation Research 85, 1173 (1999).
77. J. H. Campbell, J. L. Efendy, C. L. Han, and G. R. Campbell, Atherosclerosis V: The Fifth Saratoga Conference, edited by F. Numano and M. A. Gimbrone (2000), Vol. 902, pp. 224-229.
78. W. L. Chue, G. R. Campbell, N. Caplice, A. Muhammed, C. L. Berry, A. C. Thomas, M. B. Bennett, and J. H. Campbell, Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. Journal of Vascular Surgery 39, 859 (2004).
79. G. R. Campbell, G. Turnbull, L. N. Xiang, M. Haines, S. Armstrong, B. E. Rolfe, and J. H. Campbell, The peritoneal cavity as a bioreactor for tissue engineering visceral organs: Bladder, uterus and vas deferens. Journal of Tissue Engineering and Regenerative Medicine 2, 50 (2008).
80. M. R. Hoenig, G. R. Campbell, B. E. Rolfe, and J. H. Campbell, Tissue-engineered blood vessels-Alternative to autologous grafts? Arteriosclerosis Thrombosis and Vascular Biology 25, 1128 (2005).
81. G. R. Campbell and G. B. Ryan, Origin of myofibroblasts in the avascular capsule around free-floating intraperitoneal blood-clots. Pathology 15, 253 (1983).
82. J. H. Campbell, J. L. Efendy, C. L. Han, A. A. Girjes, and G. R. Campbell, Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. Journal of Vascular Research 37, 364 (2000).
83. H. J. M. Verhagen, G. J. HeijnenSnyder, A. Pronk, T. M. Vroom, T. vanVroonhoven, B. C. Eikelboom, J. J. Sixma, and P. G. deGroot, Thrombomodulin activity on mesothelial cells: Perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular grafts. British Journal of Haematology 95, 542 (1996).
84. H. A. Bull, R. M. Pittilo, J. Drury, J. G. Pollock, J. M. F. Clarke, N. Woolf, A. Marston, and S. J. Machin, Effects of autologous mesothelial cell seeding on prostacyclin production within dacron arterial prostheses. British Journal of Surgery 75, 671 (1988).
85. J. L. Efendy, G. R. Campbell, and J. H. Campbell, The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue. Journal of Pathology 192, 257 (2000).
86. Y. Naito, T. Shinoka, D. Duncan, N. Hibino, D. Solomon, M. Cleary, A. Rathore, C. Fein, S. Church, and C. Breuer, Vascular tissue engineering: Towards the next generation vascular grafts. Advanced Drug Delivery Reviews, In Press, Corrected Proof.
87. T. Shin'oka, G. Matsumura, N. Hibino, Y. Naito, M. Watanabe, T. Konuma, T. Sakamoto, M. Nagatsu, and H. Kurosawa, Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. Journal of Thoracic and Cardiovascular Surgery 129, 1330 (2005).
88. T. Shin'oka, Y. Imai, and Y. Ikada, Transplantation of a tissueengineered pulmonary artery. New England Journal of Medicine 344, 532 (2001).
89. M. Watanabe, T. Shin'Oka, S. Tohyama, N. Hibino, T. Konuma, G. Matsumura, Y. Kosaka, T. Ishida, Y. Imai, M. Yamakawa, Y. Ikada, and S. Morita, Tissue-engineered vascular autograft: Inferior vena cava replacement in a dog model. Tissue Engineering 7, 429 (2001).
90. T. Shinoka, D. Shum-Tim, P. X. Ma, R. E. Tanel, N. Isogai, R. Langer, J. P. Vacanti, and J. E. Mayer, Creation of viable pulmonary artery autografts through tissue engineering. Journal of Thoracic and Cardiovascular Surgery 115, 536 (1998).
91. N. Hibino, E. McGillicuddy, G. Matsumura, Y. Ichihara, Y. Naito, C. Breuer, and T. Shinoka, Late-term results of tissue-engineered vascular grafts in humans. Journal of Thoracic and Cardiovascular Surgery 139, 431 (2010).
92. N. L'Heureux, T. N. McAllister, and L. M. de la Fuente, Tissueengineered blood vessel for adult arterial revascularization. New England Journal of Medicine 357, 1451 (2007).
93. T. N. McAllister, M. Maruszewski, S. A. Garrido, W. Wystrychowski, N. Dusserre, A. Marini, K. Zagalski, A. Fiorillo, H. Avila, X. Manglano, J. Antonelli, A. Kocher, M. Zembala, L. Cierpka, L. M. de la Fuente, and N. Lheureux, Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: A multicentre cohort study. Lancet 373, 1440 (2009).